不同病情程度抑郁症患者的大脑运动皮层神经可塑性研究

注册号:

Registration number:

ChiCTR2000039441 

最近更新日期:

Date of Last Refreshed on:

2023-09-28 15:10:14 

注册时间:

Date of Registration:

2020-10-28 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

不同病情程度抑郁症患者的大脑运动皮层神经可塑性研究

Public title:

The brain plasticity mechanism research of patients with different degree of depression

注册题目简写:

English Acronym:

研究课题的正式科学名称:

不同病情程度抑郁症患者的大脑运动皮层神经可塑性研究

Scientific title:

The brain plasticity mechanism research of patients with different degree of depression

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

袁嘉蔚 

研究负责人:

刘健华 

Applicant:

Jiawei Yuan 

Study leader:

Jianhua Liu 

申请注册联系人电话:

Applicant telephone:

+86 13710104403

研究负责人电话:

Study leader's
telephone:

+86 13729889452

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

yjw46@126.com

研究负责人电子邮件:

Study leader's E-mail:

jyhf08@sina.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市大德路111号广东省中医院针灸科

研究负责人通讯地址:

广东省广州市大德路111号广东省中医院针灸科

Applicant address:

111 Dade Road, Yuexiu District, Guangzhou, Guangdong, China

Study leader's address:

111 Dade Road, Yuexiu District, Guangzhou, Guangdong, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

广东省中医院

Applicant's institution:

Guangdong Provincial Hospital of Tradition Chinese Medicine

研究负责人所在单位:

广东省中医院

Affiliation of the Leader:

Guangdong Provincial Hospital of Tradition Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

BF2020-109-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

广东省中医院伦理委员会

Name of the ethic committee:

Institution Ethics Committee of Guangdong Provincial Hospital of Tradition Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2020-07-07 00:00:00

伦理委员会联系人:

李晓彦

Contact Name of the ethic committee:

Xiaoyan Li

伦理委员会联系地址:

广东省广州市大德路111号

Contact Address of the ethic committee:

111 Dade Road, Yuexiu District, Guangzhou, Guangdong, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

广东省中医院

Primary sponsor:

Guangdong Provincial Hospital of Tradition Chinese Medicine

研究实施负责(组长)单位地址:

广东省广州市大德路111号

Primary sponsor's address:

111 Dade Road, Yuexiu District, Guangzhou, Guangdong, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

省(直辖市):

市(区县):

Country:

Province:

City:

单位(医院):

具体地址:

Institution
hospital:

Address:

经费或物资来源:

深圳市政府“医疗卫生三名工程”深圳市宝安中医院(集团)

Source(s) of funding:

Shenzhen Baoan Hospital of Tradition Chinese Medicine

研究疾病:

抑郁症  

Target disease:

depression

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究旨在探讨抑郁症患者大脑运动皮层LTP及LTD改变,观察抑郁症患者不同病情程度与脑可塑性指标的相关性。  

Objectives of Study:

The purpose of this trial is to discover long-termpotentiation and long-termdepression in the motor cortex of different degree of depressed patientsand to find the relationship between the severity of depression and brain plasticity mechanism.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

(1)既往及当前有自伤自杀计划或行为、精神病性症状者;
(2)既往诊断有精神分裂症、双相障碍或其他精神障碍类疾病;
(3)有明显的人格障碍史;
(4)有酗酒或物质滥用史;
(5)既往有脑外伤、癫痫病史。
(6)伴有肝肾功不全,有金属植入物或心脑血管系统重大疾病病情无法控制者;
(7)依从性可能较差者;
(8)左利手;
(9)妊娠及哺乳期妇女。

Exclusion criteria:

(1) History of self harm or suicide;
(2) History of schizophrenia, bipolar disorder or severe personality disorder;
(3) History of alcohol abuse or drug dependence;
(4) History of severe traumatic brain injury or epilepsy;
(5) Participants who have serious cardiovascular diseases, liver diseases or kidney diseases;
(6) People who refuse acupuncture treatment during the trial;
(7) Metal implant in skull or pacemaker;
(8) Women in pregnant or lactating.

研究实施时间:

Study execute time:

From 2020-11-01 00:00:00 To 2021-07-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-11-01 00:00:00 To 2021-04-01 00:00:00

干预措施:

Interventions:

组别:

PAS10

样本量:

70

Group:

PAS10

Sample size:

干预措施:

PAS10(健康人vs轻中重抑郁患者)

干预措施代码:

Intervention:

PAS10

Intervention code:

组别:

PAS25

样本量:

70

Group:

PAS25

Sample size:

干预措施:

PAS25(健康人vs轻中重抑郁患者

干预措施代码:

Intervention:

PAS25

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

广州 

Country:

China

Province:

GuangDong

City:

Guangzhou

单位(医院):

广东省中医院 

单位级别:

三甲 

Institution
hospital:

Guangdong Provincial Hospital of Tradition Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

运动诱发电位

指标类型:

主要指标

Outcome:

Motor evoked potentials (MEPs)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

阈值

指标类型:

次要指标

Outcome:

The resting motor threshold (rMT)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

皮层静息期

指标类型:

次要指标

Outcome:

Contralateral silent period (CSP)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

连线实验AB

指标类型:

次要指标

Outcome:

Trail making testAB

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Rey听觉词语测试

指标类型:

次要指标

Outcome:

Rey Auditory Verbal Learning Test (RAVLT)

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 50 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

研究者根据心理量表测试分数和临床心理科医生诊断将受试者分为:健康组、轻度抑郁组、中度抑郁组、重度抑郁组。采取简单随机化方法,应用PEMS3.1 for Windows“完全随机设计”程序产生随机数字(研究对象总数=70,处理组数=2/),得出顺序号,制作随机卡片,加信封密封。受试者进入试验时,按具体进入的先后次序以信封上的序号顺序拆开信封,依照随机卡片上的提示进行随机决定进行干预前后顺序。

Randomization Procedure (please state who generates the random number sequence and by what method):

According to the scores of psychological scale, the subjects were divided into four groups: healthy control group, mild depression group, moderate depression group and severe depression group。We use a computer-generated randomization digital table. 70 patients will be equally allocated into two groups.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

未说明

Blinding:

Not stated

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

临床试验公共管理平台, ResMan, http://www.medresman.org.cn.

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan, http://www.medresman.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据包括原始记录、病例记录表等数据的excel保存,采用ResMan数据库管理。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The data includes the using excel records of CRF. The ResMan database will be used.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2020-10-28 01:21:16